DNA Topoisomerases in Cancer Therapy: Present and Future

by

Write The First Customer Review

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the ...

DNA Topoisomerases in Cancer Therapy: Present and Future 2012, Springer

ISBN-13: 9781461349419

Softcover Reprint of the Origi edition

Trade paperback

Select
DNA Topoisomerases in Cancer Therapy: Present and Future 2003, Springer, New York, NY

ISBN-13: 9780306477447

2003 edition

Hardcover

Select